Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 37
2016 77
2017 70
2018 27
2019 30
2020 35
2021 48
2022 62
2023 65
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Results by year

Filters applied: . Clear all
Page 1
EFFECT OF PAXLOVID TREATMENT DURING ACUTE COVID-19 ON LONG COVID ONSET: AN EHR-BASED TARGET TRIAL EMULATION FROM THE N3C AND RECOVER CONSORTIA.
Preiss A, Bhatia A, Aragon LV, Baratta JM, Baskaran M, Blancero F, Brannock MD, Chew RF, Díaz I, Fitzgerald M, Kelly EP, Zhou A, Carton TW, Chute CG, Haendel M, Moffitt R, Pfaff E. Preiss A, et al. medRxiv [Preprint]. 2024 Apr 4:2024.01.20.24301525. doi: 10.1101/2024.01.20.24301525. medRxiv. 2024. PMID: 38343863 Free PMC article. Preprint.
Nonelective coronary artery bypass graft outcomes are adversely impacted by Coronavirus disease 2019 infection, but not altered processes of care: A National COVID Cohort Collaborative and National Surgery Quality Improvement Program analysis.
Grimsley EA, Torikashvili JV, Janjua HM, Read MD, Kothari AN, Verhagen NB, Pietrobon R, Kuo PC, Rogers MP; N3C Consortium. Grimsley EA, et al. JTCVS Open. 2023 Sep 22;16:342-352. doi: 10.1016/j.xjon.2023.09.020. eCollection 2023 Dec. JTCVS Open. 2023. PMID: 38204718 Free PMC article.
Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma.
Mitra AK, Mukherjee UK, Mazumder S, Madhira V, Bergquist T, Shao YR, Liu F, Song Q, Su J, Kumar S, Bates BA, Sharafeldin N, Topaloglu U; National COVID Cohort Collaborative Consortium. Mitra AK, et al. Blood Cancer J. 2023 Dec 7;13(1):180. doi: 10.1038/s41408-023-00901-y. Blood Cancer J. 2023. PMID: 38057320 Free PMC article.
395 results